Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/1/2020
SIETES contiene 92879 citas

 
 
<< anterior 21 a 40 de 711 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Ferro A. Newer antiplatelet agents in acute coronary syndrome. BMJ 2016;352:h7025. [Ref.ID 99965]
22.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
23.Enlace a cita originalTiene citas relacionadas Cita con resumen
Schoenfeld AJ, Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med 2016;176:febrero. [Ref.ID 99958]
24. Cita con resumen
Voelker R. No increased risk of death with clopidogrel. JAMA 2015;314:2497. [Ref.ID 99759]
25. Cita con resumen
Young K. Who might benefit from long-term DAPT? Risk score may help . Journal Watch 2015:1. [Ref.ID 99636]
26. Cita con resumen
Olsen A-MS, Lindhardsen J, Gislason GH, McGettigan P, Hlatky MA, Fosbøl E, Køber L, Torp-Pedersen C, Lamberts M. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study. BMJ 2015;351:h5096. [Ref.ID 99631]
28.Enlace a cita original Cita con resumen
Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN, for the Canadian Drug Safety Effectiveness Research Network (CDSERN). A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 2015;80:662-9. [Ref.ID 99608]
29. Cita con resumen
Tinetti ME, McAvay G, Trentalange M, Cohen AB, Allore HG. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ 2015;351:h4984. [Ref.ID 99591]
30. Cita con resumen
Giustino G, Baber U, Sartori S, Mehran M, Mastoris I, Kini AS, Sharma SK, Pocock SJ, Dangas GD. Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.. Journal of The Americal College of Cardiology 2015;65:1298-310. [Ref.ID 99446]
31. Cita con resumen
Pandit A, Giri S, Hakim FA, Fortiun FD. Shorter (=6 months) versus longer (=12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials. Catheterization and Cardiovascular Interventions 2015;85:34-40. [Ref.ID 99445]
32. Cita con resumen
Anónimo. Gluconorm (repaglinide) - New contraindication for concomitant use with clopidogrel . Healthy Canadians 2015:31 de julio. [Ref.ID 99386]
34.Tiene citas relacionadas
Wiviott SD, Steg PG. Clinical evidence for oral antiplatelet therapy in acute coronary syndromes. Lancet 2015;386:292-302. [Ref.ID 99357]
36. Cita con resumen
Spencer FA, Prasad M, Vandvik PO, Chetan D, Zhou Q, Guyatt G. Longer versus shorter duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis. Ann Intern Med 2015;163:118-26. [Ref.ID 99119]
37.Tiene citas relacionadas
Mauri L, Yeh RW, Kereiakes DJ. Duration of dual antiplatelet therapy after drug-eluting stents. The authors reply. N Engl J Med 2015;372:1374. [Ref.ID 99009]
38.Tiene citas relacionadas
Tomoda H. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1373. [Ref.ID 99008]
39.Tiene citas relacionadas
Pfisterer M, Kaiser C, Jeger R. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371-2. [Ref.ID 99007]
40.Tiene citas relacionadas
Marrs JC. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2015;372:1371-2. [Ref.ID 99006]
Seleccionar todas
 
<< anterior 21 a 40 de 711 siguiente >>